PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 Medicxi Announces €500 Million Fund V Medicxi
17-Nov-2025 CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update ACCESS Newswire
17-Nov-2025 Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump ACCESS Newswire
17-Nov-2025 NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position ACCESS Newswire
17-Nov-2025 IGC Pharma Reports Accelerated Q2 Progress and Strengthened Financial Focus: CALMA Trial Passes 50% Enrollment Milestone, Strategic Divestiture Optimizes Capital ACCESS Newswire
17-Nov-2025 Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs ACCESS Newswire
17-Nov-2025 Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue ACCESS Newswire
17-Nov-2025 Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin ACCESS Newswire
17-Nov-2025 OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma ACCESS Newswire
17-Nov-2025 Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic Captain T Cell
17-Nov-2025 Autologous Cell Therapy Product Market Forecast: A New Era of Personalized Therapies Vantage Market Research